研究者
J-GLOBAL ID:202301010312170071
更新日: 2024年01月30日
中村 俊文
Nakamura Toshifumi
競争的資金等の研究課題 (1件):
- 2017 - 2019 尿細管MR機能との比較を通じた腸管MRの血圧代謝関連病態における新たな意義の解明
論文 (10件):
-
Stefanny M Figueroa, Jean-Philippe Bertocchio, Toshifumi Nakamura, Soumaya El-Moghrabi, Frédéric Jaisser, C. A. Amador. The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice. Pharmaceutics. 2023. 15. 5. 1373-1373
-
Rie Jo, Hirotaka Shibata, Isao Kurihara, Kenichi Yokota, Sakiko Kobayashi, Ayano Murai-Takeda, Yuko Mitsuishi, Takeshi Hayashi, Toshifumi Nakamura, Hiroshi Itoh. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertension Research. 2022. 46. 1. 19-31
-
Van Tuan Nguyen, Qui Trung Ngo, Roberto Palacios Ramirez, Toshifumi Nakamura, Nicolette Farman, Sélim Aractingi, Frederic Jaisser. The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid-induced impaired wound healing. British Journal of Pharmacology. 2022. 179. 23. 5222-5232
-
Toshifumi Nakamura, Benjamin Bonnard, Roberto Palacios-Ramirez, Amaya Fern{\'{a } }ndez-Celis, Fr{\'{e } }d{\'{e } }ric Jaisser, Natalia L{\'{o } }pez-Andr{\'{e } }s. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury. International Journal of Molecular Sciences. 2022. 23. 12. 6680-6680
-
Toshifumi Nakamura, Sophie Girerd, Frederic Jaisser, Jonatan Barrera-Chimal. Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease. Kidney International Supplements. 2022. 12. 1. 12-18
もっと見る
前のページに戻る